Oncology
2366 articles · 70 journals
Journals in this subcategory (70)
- Blood Neoplasia · Elsevier (100)
- European Journal of Surgical Oncology · Elsevier (95)
- Cancer Treatment and Research Communications · Elsevier (93)
- The Lancet Oncology · Elsevier (93)
- Brachytherapy · Elsevier (91)
- Cancer Epidemiology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- International Journal of Gynecological Cancer · Elsevier (88)
- EJC Skin Cancer · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (84)
- Lung Cancer · Elsevier (77)
- Asia-Pacific Journal of Clinical Oncology · Wiley (76)
- Critical Reviews in Oncology/Hematology · Elsevier (70)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (68)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Cancer Letters · Elsevier (57)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (25)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Risk factors for early-onset cancers: Results from the JANUS cohort in Norway
- Table of contents
- Isocitrate dehydrogenase mutations as potential tumour agnostic targets
- Clinical advancement in the management of mutant isocitrate dehydrogenase (IDH) cancers
- Liver cancer incidence trends in younger versus older adults over time: an analysis of population-based cancer registry data
- Vitamin D supplementation, cancer incidence and mortality: Randomized trials revisited
- DNA methylation-based immune profiling reveals distinct subtypes in esophageal adenocarcinoma
- Targeting IL-12 and IL-23 in immune-related adverse events from checkpoint inhibitors: current evidence and future directions
- Broadening the tumor antigens panorama for cancer vaccines – All the way to the dark matter of the genome
- Computational image features of immune architecture reveal molecular patterns associated with outcome and risk of recurrence in microsatellite-stable or MSI-low colon cancers
- What does addressing cancer inequalities really mean? Five principles that can drive global action
- Letter Re: Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis
- Response to letter Re: Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis
- Multimodal treatment of isolated leptomeningeal relapse in BRAF-mutated dMMR colon cancer
- Letter Re: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer
- Cemiplimab plus chemotherapy versus chemotherapy in non-small-cell lung cancer with PD-L1 ≥1%: 5-year update of EMPOWER-Lung 3 Part 2 results
- APOBEC3-mediated therapy resistance and immunogenicity in solid tumors: from genomic scars to therapeutic vulnerabilities
- PD-L1 assessment in Merkel cell carcinoma: Predictive implications for anti-PD-1 and anti-PD-L1 therapy
- 10-years of first-line ipilimumab and nivolumab in the management of melanoma brain metastases: a single centre experience
- Immune-related pneumonitis: A retrospective analysis of corticosteroid requirements and the role of hydroxychloroquine in melanoma patients
- The recurrence rate of malignant melanoma treated with staged micrographic excision in South Africa: A retrospective study
- Dermatofibrosarcoma protuberans in South Africa: Outcomes of staged excision and peripheral and deep en face margin assessment (PDEMA) and recommendations for wide local excision margins
- A phase II, open-label study to improve compliance and time of treatment after obtaining complete response (CR) through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (LA BCC) – the SONIBEC trial
- Single-center clinico-genomic analysis of KIT mutated melanomas and clinical outcomes with tyrosine kinase inhibitor treatment
- Living with advanced or metastatic melanoma: A patient-driven conceptual model
- From immune activation to pathological response: neoadjuvant immunotherapy in cutaneous squamous cell carcinoma. A systematic review and meta-analysis
- Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced cutaneous squamous cell carcinoma
- Outcomes and prognostic factors of immune checkpoint inhibitor resumption in advanced melanoma, results from the MIRROR (melanoma immunotherapy resumption: Retrospective outcomes review) multicenter real-world study
- The survivorship experience of people with stage II-IV melanoma receiving adjuvant therapy: A real-world, prospective, longitudinal study
- Ten-year outcomes after initial response to immune checkpoint inhibitors in patients with advanced Merkel cell carcinoma